Measurement of urinary S100B protein concentrations for the early identification of brain damage in asphyxiated full-term infants.

BACKGROUND Perinatal asphyxia is a major cause of mortality and morbidity. To date there are no reliable methods to detect which infants will develop brain damage after asphyxia insult. We investigated whether measurements of urine levels of S100B in asphyxiated full-term newborns may be a useful tool for early detection of postasphyxia brain damage. METHODS A prospective study of 38 infants with perinatal asphyxia and 96 control subjects, recruited at 3 tertiary departments of neonatology between April 1, 1999, and July 31, 2001. Routine laboratory variables, neurologic patterns, and urine concentrations of S100B protein were determined at 4 predetermined time points (first urination and 12, 24, and 72 hours after birth). The concentrations of S100B protein in urine were measured using an immunoluminometric assay. The results were correlated with the presence or absence of neurologic abnormalities at age 12 months. RESULTS S100B protein levels were significantly higher in samples collected at all monitoring times from new-borns with abnormal neurologic findings on follow-up (first urination, 1.92 +/- 0.33 micro g/L; 12 hours, 2.78 +/- 1.71 micro g/L; 24 hours, 4.75 +/- 4.08 micro g/L; 72 hours, 5.93 +/- 1.63 micro g/L) than in samples from those without (first urination, 0.24 +/- 0.06 micro g/L; 12 hours, 0.13 +/- 0.06 micro g/L; 24 hours, 0.21 +/- 0.07 micro g/L; 72 hours, 0.12 +/- 0.04 micro g/L) or from healthy infants (first urination, 0.11 +/- 0.01 micro g/L; 12 hours, 0.12 +/- 0.03 micro g/L; 24 hours, 0.12 +/- 0.02 micro g/L; 72 hours, 0.12 +/- 0.02 micro g/L) (P<.001 for all). An S100B concentration cutoff of 0.28 micro g/L at first urination had a sensitivity of 100% and a specificity of 87.3% for predicting the development of abnormal neurologic findings on follow-up. The sensitivity and specificity of measurements obtained between 12 and 72 hours were up to 100% and 98.2%, respectively. CONCLUSION Longitudinal S100B protein measurements in urine soon after birth are a useful tool to identify which asphyxiated infants are at risk of long-term neurologic sequelae.

[1]  C. Heizmann.  Ca2+-Binding S100 Proteins in the Central Nervous System , 1999, Neurochemical Research.

[2]  ACOG Committee Opinion #303: Inappropriate use of the terms fetal distress and birth asphyxia. , 2004, Obstetrics and gynecology.

[3]  F. Michetti,et al.  S100B protein in biological fluids: a tool for perinatal medicine. , 2002, Clinical chemistry.

[4]  F. Michetti,et al.  S100B protein is increased in asphyxiated term infants developing intraventricular hemorrhage , 2002, Critical care medicine.

[5]  F. Michetti,et al.  Circulating S100β Protein Is Increased in Intrauterine Growth-Retarded Fetuses , 2002, Pediatric Research.

[6]  F. Michetti,et al.  Increased urinary S100B protein as an early indicator of intraventricular hemorrhage in preterm infants: correlation with the grade of hemorrhage. , 2001, Clinical chemistry.

[7]  D. Gazzolo,et al.  Circulating Adrenomedullin Is Increased in Preterm Newborns Developing Intraventricular Hemorrhage , 2001, Pediatric Research.

[8]  F. Michetti,et al.  S100b protein concentrations in urine are correlated with gestational age in healthy preterm and term newborns. , 2001, Clinical chemistry.

[9]  C. Müller,et al.  Early Biochemical Indicators of Hypoxic-Ischemic Encephalopathy after Birth Asphyxia , 2001, Pediatric Research.

[10]  B Hagberg,et al.  Changing panorama of cerebral palsy in Sweden. VIII. Prevalence and origin in the birth year period 1991–94 , 2001, Acta paediatrica.

[11]  C. Alling,et al.  Elimination of S100B and renal function after cardiac surgery. , 2000, Journal of cardiothoracic and vascular anesthesia.

[12]  H. Spekreijse,et al.  Predictive value of neonatal neurological tests for developmental outcome of preterm infants. , 2000, The Journal of pediatrics.

[13]  F. Michetti,et al.  S100B protein concentrations in cord blood: correlations with gestational age in term and preterm deliveries. , 2000, Clinical chemistry.

[14]  D. Gazzolo,et al.  Adrenomedullin is increased in the fetoplacental circulation in intrauterine growth restriction with abnormal umbilical artery waveforms. , 2000, American journal of obstetrics and gynecology.

[15]  K. Haglid,et al.  Elevated S100 blood level as an early indicator of intraventricular hemorrhage in preterm infants Correlation with cerebral Doppler velocimetry , 1999, Journal of the Neurological Sciences.

[16]  Peggy Wu,et al.  Measurement of the urinary lactate:creatinine ratio for the early identification of newborn infants at risk for hypoxic-ischemic encephalopathy. , 1999, The New England journal of medicine.

[17]  J. Brown,et al.  An international network for evaluating neuroprotective therapy after severe birth asphyxia. , 1999, Seminars in perinatology.

[18]  M. Sherman,et al.  Interventions for perinatal hypoxic-ischemic encephalopathy. , 1998, Pediatrics.

[19]  P. Ilves,et al.  Changes in Doppler ultrasonography in asphyxiated term infants with hypoxic‐ischaemic encephalopathy , 1998, Acta paediatrica.

[20]  F. Michetti,et al.  S100 blood concentrations in children subjected to cardiopulmonary by-pass. , 1998, Clinical chemistry.

[21]  Adriana B Ferreira,et al.  S100β Induces Neuronal Cell Death Through Nitric Oxide Release from Astrocytes , 1997, Journal of neurochemistry.

[22]  D. Harris,et al.  Neurone-specific enolase and Sangtec 100 assays during cardiac surgery: part I - the effects of heparin, protamine and propofol , 1997, Perfusion.

[23]  A. Hamberger,et al.  S-100β stimulates neurite outgrowth in the rat sciatic nerve grafted with acellular muscle transplants , 1997, Brain Research.

[24]  C. Heizmann,et al.  The S100 family of EF-hand calcium-binding proteins: functions and pathology. , 1996, Trends in biochemical sciences.

[25]  I. Rosén,et al.  Predictive value of early continuous amplitude integrated EEG recordings on outcome after severe birth asphyxia in full term infants. , 1995, Archives of disease in childhood. Fetal and neonatal edition.

[26]  R. Strauss.  Neonatal anemia: pathophysiology and treatment. , 1995 .

[27]  K. Nelson,et al.  Intrapartum asphyxia and cerebral palsy. , 1988, Pediatrics.

[28]  R. Rivers,et al.  Cerebral blood flow velocity variability in infants receiving assisted ventilation. , 1988, Archives of disease in childhood.

[29]  H. Hårdemark,et al.  S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. , 1987, Stroke.

[30]  D. Marshak,et al.  Characterization of Human Brain S100 Protein Fraction: Amino Acid Sequence of S100β , 1985, Journal of neurochemistry.

[31]  K. Haglid,et al.  Purification, characterization and ion binding properties of human brain S100b protein. , 1984, Biochimica et biophysica acta.

[32]  F. Michetti,et al.  The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the nervous system , 1980, Journal of the Neurological Sciences.

[33]  V. Fidler,et al.  Preterm birth, growth retardation and acidemia in relation to neurological abnormality of the newborn. , 1979, Early human development.

[34]  F. Michetti,et al.  The nervous system-specific S-100 antigen in cerebrospinal fluid of multiple sclerosis patients , 1979, Neuroscience Letters.

[35]  H. Sarnat,et al.  Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. , 1976, Archives of neurology.

[36]  C. Amiel‐Tison.  Neurological evaluation of the maturity of newborn infants. , 1968, Archives of disease in childhood.